| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |